A Safety and Effectiveness Study of a Single Dose of JNJ-17216498 in Patients With Narcolepsy

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

November 30, 2007

Study Completion Date

December 31, 2007

Conditions

Narcolepsy

Interventions

DRUG

JNJ-17216498

50mg one time

DRUG

JNJ-17216498

10mg one time

DRUG

Modafinil

200 mg X 2

Trial Locations (16)

Birmingham

Phoenix

Tucson

San Diego

Stanford

Spring Hill

St. Petersburg

Macon

Danville

Fort Wayne

Amherst

Cincinnati

Toledo

Columbia

Houston

Spokane

All Listed Sponsors

lead

Alza Corporation, DE, USA

INDUSTRY

NCT00424931 - A Safety and Effectiveness Study of a Single Dose of JNJ-17216498 in Patients With Narcolepsy | Biotech Hunter | Biotech Hunter